Y. Regmi, G. Sapkota, and B. Wagle, “Role of Intravenous Ketamine as Adjuvant to Opioids in Refractory Cancer Pain: Case Report”, Nep. J. Cancer, vol. 3, no. 1, pp. 49–53, Oct. 2019.